1Turnbull DM, Shepherd IM, Ashworth B, et al. Lipid storage myopathy associated with low acyl-CoA dehydrogenase activities.Brain, 1988, 111: 815-828.
2Hsu CC, Chuang YH, Tsai JL, et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol Scand, 1995, 92:252-255.
3Tein I. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy. J Child Neurol, 2002, 17 Suppl 3:3S57-3S83.
4Munoz-Malaga A, Bautista J, Salazar JA, et al. Lipomatosis,proximal myopathy, and the mitochondrial 8344 mutation. A lipid storage myopathy? Muscle Nerve, 2000, 23: 538-542.
同被引文献9
1Di Donato S, Cornelio F, Balestrini MR, et al. Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency. Neurology, 1978, 28 : 1110-1116.
2Roodhooft AM, Van Aeker KJ, Martin JJ, et al. Benign mitochondrial myopathy with deficiency of NADH-CoQ reduclase and cytochrome c oxidase. Neuropediatrics, 1986, 17: 221-226.
3Jerusalem F, Angelini C, Engel AG, et al. Mitochondria-lipid-glycogen (MLG) disease of muscle. A morphologically regressive congenital myopathy. Arch Neurol, 1973, 29: 162-169.
4Kaufmann P, Koga Y, Shanske S, et al. Mitochondrial DNA and RNA processing in MELAS. Ann. Neurol,1996,40(2):172-180.
5Farrants GW, Hovmoller S, Stadhouders AM. Two types of mito chondrial crystals in diseased human skeletal muscle fibers. Muscle Nerve, 1988,11(1) :45-55.
